Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism.
D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001389:Azirines / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D001590:Benztropine / Q000494:pharmacology; D002540:Cerebral Cortex / Q000378:metabolism*; D003342:Corpus Striatum / Q000201:enzymology; D003984:Dibenzazepines / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D005116:Extrapyramidal Tracts / Q000187:drug effects*; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D010276:Parasympatholytics / Q000494:pharmacology*; D010640:Phenothiazines / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D013141:Spiro Compounds / Q000494:pharmacology; D013881:Thioridazine / Q000494:pharmacology; D013892:Thioxanthenes / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology; D014316:Tritium
D000067956:Adenylyl Cyclase Inhibitors; D001389:Azirines; D001565:Benzoates; D003984:Dibenzazepines; D010276:Parasympatholytics; D010640:Phenothiazines; D010879:Piperazines; D011955:Receptors, Drug; D013141:Spiro Compounds; D013892:Thioxanthenes; D014149:Tranquilizing Agents; D014316:Tritium; D010868:Pimozide; D001590:Benztropine; D014268:Trifluoperazine; D000431:Ethanol; D001285:Atropine; D013881:Thioridazine